UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1568) 1568
science & technology (1424) 1424
life sciences & biomedicine (1385) 1385
female (874) 874
male (872) 872
catheter-related infections - microbiology (618) 618
middle aged (609) 609
catheter-related infections - drug therapy (557) 557
aged (518) 518
infectious diseases (504) 504
adult (462) 462
catheter-related infections - prevention & control (436) 436
catheterization, central venous - adverse effects (422) 422
anti-bacterial agents - therapeutic use (406) 406
catheter-related infections - epidemiology (381) 381
risk factors (367) 367
catheters (324) 324
retrospective studies (306) 306
microbiology (302) 302
biological and medical sciences (299) 299
health aspects (297) 297
medical sciences (288) 288
treatment outcome (286) 286
catheter-related infections - etiology (268) 268
catheters, indwelling - adverse effects (264) 264
child (231) 231
aged, 80 and over (230) 230
catheter-related infections - diagnosis (222) 222
bacteremia - microbiology (220) 220
infections (216) 216
adolescent (215) 215
bacteremia - drug therapy (213) 213
prospective studies (185) 185
urology & nephrology (178) 178
incidence (177) 177
young adult (176) 176
infection (174) 174
child, preschool (169) 169
general & internal medicine (165) 165
pediatrics (165) 165
pharmacology & pharmacy (162) 162
antibiotics (161) 161
anti-bacterial agents - administration & dosage (156) 156
infant (151) 151
bacteremia - etiology (149) 149
bacteremia (148) 148
central venous catheters - adverse effects (148) 148
care and treatment (140) 140
catheter-related infections (138) 138
oncology (136) 136
microbial sensitivity tests (135) 135
nosocomial infections (135) 135
infectious disease (134) 134
time factors (134) 134
bacteremia - epidemiology (133) 133
cross infection - microbiology (130) 130
catheterization (129) 129
catheterization, central venous - instrumentation (127) 127
analysis (126) 126
central venous catheter (125) 125
research (125) 125
cross infection - epidemiology (124) 124
catheters, indwelling - microbiology (123) 123
staphylococcal infections - drug therapy (122) 122
prevention (118) 118
biofilms - drug effects (113) 113
hemodialysis (113) 113
mortality (113) 113
bacteremia - prevention & control (111) 111
cross infection - drug therapy (111) 111
central venous catheters (109) 109
antifungal agents - therapeutic use (107) 107
anti-bacterial agents - pharmacology (104) 104
nursing (104) 104
bacterial diseases (103) 103
patients (103) 103
cancer (102) 102
biofilms (101) 101
immunology (101) 101
cross infection - prevention & control (100) 100
medicine & public health (100) 100
infant, newborn (99) 99
staphylococcal infections - microbiology (98) 98
hematology (97) 97
medicine, general & internal (96) 96
cross infection (95) 95
human bacterial diseases (95) 95
surgery (92) 92
complications and side effects (91) 91
blood (89) 89
public, environmental & occupational health (89) 89
animals (87) 87
catheter-related infection (87) 87
chemotherapy (87) 87
pharmacology. drug treatments (87) 87
infection control (86) 86
neoplasms - drug therapy (86) 86
renal dialysis - adverse effects (86) 86
abridged index medicus (85) 85
intensive care units (85) 85
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1658) 1658
Spanish (60) 60
French (26) 26
German (15) 15
Japanese (12) 12
Portuguese (10) 10
Turkish (10) 10
Italian (7) 7
Czech (3) 3
Chinese (2) 2
Danish (2) 2
Croatian (1) 1
Finnish (1) 1
Norwegian (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infectious diseases, ISSN 0022-1899, 11/2014, Volume 210, Issue 9, pp. 1357 - 1366
Biofilms | Antibiotics | Escherichia coli | Bacteria | Aminoglycosides | Pseudomonas aeruginosa | Infections | Basic amino acids | Staphylococcus aureus | aminoglycoside | persister | catheter-related infections | biofilm | proton motive force | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Escherichia coli Infections - prevention & control | Central Venous Catheters - microbiology | Escherichia coli - drug effects | Gentamicins - administration & dosage | Catheter-Related Infections - prevention & control | Pseudomonas Infections - prevention & control | Arginine - administration & dosage | Gentamicins - pharmacology | Drug Therapy, Combination | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Pseudomonas Infections - drug therapy | Rats | Central Venous Catheters - adverse effects | Pseudomonas aeruginosa - drug effects | Catheter-Related Infections - drug therapy | Drug Synergism | Animals | Arginine - pharmacology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | In Vitro Techniques | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Health aspects | Research | Index Medicus | Abridged Index Medicus | Biofilms/drug effects | Gentamicins/administration & dosage | Anti-Bacterial Agents/pharmacology | Staphylococcal Infections/drug therapy | Arginine/administration & dosage | Life Sciences | Escherichia coli Infections/drug therapy | Staphylococcus aureus/drug effects | Gentamicins/pharmacology | Catheter-Related Infections/prevention & control | Pseudomonas aeruginosa/drug effects | Staphylococcal Infections/prevention & control | Catheter-Related Infections/drug therapy | Central Venous Catheters/microbiology | Escherichia coli/drug effects | Bacteriology | Microbiology and Parasitology | Central Venous Catheters/adverse effects | Arginine/pharmacology | Pseudomonas Infections/prevention & control | Escherichia coli Infections/prevention & control | Pseudomonas Infections/drug therapy
Journal Article
Burns, ISSN 0305-4179, 2016, Volume 43, Issue 3, pp. 642 - 653
Critical Care | Nosocomial infection | Burn wound infection | Pneumonia | Urinary tract infection | Health care related infection | Burns | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Dermatology | Surgery | Science & Technology | Escherichia coli | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Folliculitis - epidemiology | Aged, 80 and over | Urinary Tract Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Staphylococcus aureus | Escherichia coli Infections - drug therapy | Bacteremia - drug therapy | Pseudomonas Infections - microbiology | Wound Infection - epidemiology | Catheter-Related Infections - drug therapy | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Acinetobacter baumannii | Catheter-Related Infections - microbiology | Adolescent | Bacteremia - epidemiology | Infant | Bacteremia - microbiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Adult | Female | Pseudomonas aeruginosa | Staphylococcal Infections - microbiology | Wound Infection - drug therapy | Acinetobacter Infections - microbiology | Staphylococcal Infections - drug therapy | Colombia - epidemiology | Klebsiella Infections - drug therapy | Central Venous Catheters | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Folliculitis - microbiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Oxacillin - therapeutic use | Burns - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Wound Infection - microbiology | Aged | Folliculitis - drug therapy | Klebsiella pneumoniae | Development and progression | Burns and scalds | Surgery, Plastic | Health aspects | Staphylococcus aureus infections | Analysis | Bacterial pneumonia | Mortality | Urinary tract infections | Bacteria | Disease susceptibility | Antibacterial agents | Index Medicus
Journal Article
European journal of clinical microbiology & infectious diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime | Index Medicus
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 05/2015, Volume 21, Issue 1, pp. S1 - S25
Journal Article
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 1/2009, Volume 48, Issue 2, pp. 203 - 212
Control groups | Pathogens | Health outcomes | Microbiology | Mortality | Articles and Commentaries | Infections | Dosage | Catheters | Bacteremia | Blood | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Human infectious diseases. Experimental studies and models | General aspects | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Bacterial sepsis | Antibiotics. Antiinfectious agents. Antiparasitic agents | Linezolid | Humans | Middle Aged | Cross Infection - mortality | Gram-Positive Bacterial Infections - mortality | Bacteremia - mortality | Male | Oxazolidinones - adverse effects | Skin Diseases, Bacterial - drug therapy | Oxazolidinones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Acetamides - therapeutic use | Acetamides - adverse effects | Aged, 80 and over | Catheter-Related Infections - mortality | Adult | Female | Anti-Bacterial Agents - adverse effects | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Skin Diseases, Bacterial - mortality | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Vancomycin - adverse effects | Vancomycin - therapeutic use | Adolescent | Aged | Gram-Positive Bacterial Infections - drug therapy | Gram-Negative Bacterial Infections - mortality | Infectious skin diseases | Blood-borne diseases | Care and treatment | Dosage and administration | Research | Antibiotics | Comparative studies | Skin | Drug therapy | Clinical outcomes | Index Medicus
Journal Article
Journal of critical care, ISSN 0883-9441, 2016, Volume 34, pp. 116 - 120
Critical Care | Nosocomial infection | ICU | Antimicrobial resistance | Nigeria | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Klebsiella pneumoniae - isolation & purification | Staphylococcus aureus - physiology | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Bacteremia - microbiology | Microbial Sensitivity Tests | Young Adult | Anti-Bacterial Agents - therapeutic use | Surgical Wound Infection - drug therapy | Klebsiella pneumoniae - physiology | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Staphylococcal Infections - microbiology | Escherichia coli - physiology | Cloxacillin - therapeutic use | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Intensive Care Units | Pneumonia, Bacterial - microbiology | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Tertiary Care Centers | Staphylococcus aureus - isolation & purification | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Klebsiella Infections - microbiology | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Catheter-Related Infections - drug therapy | Ceftriaxone - therapeutic use | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Pneumonia, Bacterial - drug therapy | Surgical Wound Infection - microbiology | Index Medicus
Journal Article
Annals of hematology, ISSN 0939-5555, 1/2014, Volume 93, Issue 1, pp. 13 - 32
Journal Article